The present invention relates to the treatment and prevention of vasospasm.The present invention provides a system for treating a cerebral vasospasm ina human utilizing a pharmaceutical composition and administrating a therapeuticallyeffective amount of the pharmaceutical composition to a predetermined locationin close proximity to a cerebral artery within a subarachnoid space wherein thepharmaceutical composition produces a localized pharmacologic effect therebytreating the cerebral vasospasm.